16 April 2020 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
People with tetraplegia resulting from spinal cord injury experience debilitating hand impairments that may lead to lifelong dependence on others to perform activities of daily living. Wearable robotic devices that actively support hand function during daily living tasks could bring great benefits to this population. In this work, the performance of a textile-based soft robotic glove controlled by the user with a button was evaluated in thirteen participants with tetraplegia. Performance outcomes included activities of daily living using the Jebsen Taylor Hand Function Test, active range of motion of the fingers, and grasp strength for power and pinch grasps. In the Jebsen Test, participants showed significant improvements in performance of activities of daily living with glove assistance, completing a median of 50% more tasks than in their baseline attempt without the glove. Significant improvements were also found for power and pinch grasp forces and active range of motion of the fingers with the glove assistance. Participants with lower baseline motor function received greater benefits from glove assistance. This work demonstrates the effectiveness of a user-controlled textile-based soft robotic glove to improve activity of daily living abilities in individuals with hand impairments resulting from spinal cord injury.
7 August 2017 in The Journal of Spinal Cord Medicine
Objectives: Identify clinical and pathophysiologic insights into autonomic dysreflexia (AD) in patients with spinal cord injury (SCI). Study Design: Analysis of prospectively gathered AD dataset. Setting: Inpatient Veterans Affairs SCI unit. Participants: 78 male patients with SCI who experienced AD. Methods: Statistical methods were utilized to identify the frequency of relative bradycardia vs. tachycardia during AD, the effectiveness of supplemental opioids in managing suspected nociceptive pain mediated AD, the effect of chronicity of SCI on response to pharmacological management of AD, and the response to nitroglycerin ointment in suspected bladder related AD. Results: 445 episodes of AD were analyzed. The frequency of relative bradycardia and tachycardia with AD were 0.3% and 68.0% respectively. The addition of opioids to an antihypertensive medication protocol did not significantly decrease AD episode duration or magnitude of systolic blood pressure (SBP) change. A strongly matched positive linear correlation was identified between the duration of pharmacologically treated AD episodes and chronicity of SCI (R2=0.83). Bladder related AD episodes treated with nitroglycerin ointment had a faster onset of action (10.8 minutes vs. 15.9 minutes), faster time to reach a safe target blood pressure (16.5 minutes vs 20.9 minutes), and greater decrease in SBP (84.3mmHg vs. 68.6mmHg) than non-bladder related episodes (P=0.19, 0.23, and 0.02 respectively). Conclusions: AD may commonly occur with relative tachycardia. While further investigation is needed on the effects of chronicity of SCI and pharmacologic management, this study raises multiple directions for future research to understand clinical signs and treatment variables of AD following SCI.
12 March 2020 in Clinical Autonomic Research
2 September 2019 in The Journal of Spinal Cord Medicine
Context/objective: To determine current barriers for clinical implementation of epidural stimulation for functional improvement after spinal cord injury and highlight applicable ethical constructs to approach future research. Design: Survey of spinal cord injury medicine physicians, January 2019. Setting: Spinal cord injury model systems hospital sites across the United States. Participants: Spinal cord injury medicine physicians. Interventions: NA. Outcome measures: Physician-identified current barriers to clinical implementation of epidural stimulation. Results: The response rate for the survey was 54.6% (n = 42), with the majority of physicians (61.9%) having been asked by patients with spinal cord injuries about epidural stimulation. Numerous current barriers to clinical implementation were identified, including need for additional efficacy studies (92.9%), lack of clear guidelines on stimulation parameters (83.3%), and inability to identify which patients will benefit (76.2%). Conclusions: With multiple barriers to clinical implementation currently identified, evaluating this research with an eye toward the ethical construct of equipoise is increasingly relevant. Addressing these barriers may require modifications in both physician expectations and how researchers approach this work.